Mean and variability of annual haemoglobin A1c are associated with high-risk peripheral artery disease
- PMID: 32148085
- PMCID: PMC7510362
- DOI: 10.1177/1479164120909030
Mean and variability of annual haemoglobin A1c are associated with high-risk peripheral artery disease
Abstract
Background: Glucose variability is predictive of cardiovascular events and all-cause mortality. However, the association between peripheral artery disease and glucose variability has not been thoroughly investigated. Therefore, the standard deviation of annual haemoglobin A1c was assessed in patients with type 2 diabetes for evaluating the different risks of peripheral artery disease.
Methods: A total of 4144 patients underwent an evaluation for the ankle-brachial index and the percentage of mean arterial pressure at the ankle. The first haemoglobin A1c record was retrospectively collected from each year until the ankle-brachial index measurement.
Results: The standard deviation of annual haemoglobin A1c was higher in patients with ankle-brachial index ⩽0.90 than in those with ankle-brachial index >0.90 (1.1 ± 0.9% vs 1.0 ± 0.8%, p = 0.009) and was higher in patients with percentage of mean arterial pressure ⩾45% than in those with percentage of mean arterial pressure <45% (1.1 ± 0.8% vs 1.0 ± 0.8%, p = 0.007). A high standard deviation and mean of annual haemoglobin A1c are associated with high-risk peripheral artery disease, which is defined as a combination of ankle-brachial index ⩽0.90, percentage of mean arterial pressure ⩾45% or both (odds ratio = 1.306; 95% confidence interval = 1.057-1.615; p = 0.014).
Conclusion: Fluctuation in the haemoglobin A1c value indicates higher risk for peripheral artery disease in patients with type 2 diabetes and poor glucose control.
Keywords: Ankle-brachial index; haemoglobin A1c; percentage of the mean arterial pressure; peripheral artery disease; type 2 diabetes; variability.
Conflict of interest statement
Figures
References
-
- American Diabetes Association. 9. Pharmacologic approach-es to glycemic treatment: standards of medical care in diabetes-2019. Diabetes Care 2019; 42: S90–S102. - PubMed
-
- Takao T, Matsuyama Y, Yanagisawa H, et al. Association between HbA1c variability and mortality in patients with type 2 diabetes. J Diabetes Complications 2014; 28: 494–499. - PubMed
-
- Orsi E, Solini A, Bonora E, et al. Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes. Diabetes Obes Metab 2018; 20: 1885–1893. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
